Floatz logo

ANTI-PD-L1 MONOCLONAL ANTIBODY KN035

HER2 Positive Breast Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitymonoclonal_antibodyPhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

188 Active assets in the HER2 Positive Breast Carcinoma cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
SWOG Cancer Research Network
Phase 4BB
TRASTUZUMAB
SWOG Cancer Research Network
Phase 4BB
Ribociclib
Danish Breast Cancer Cooperative Group
Phase 3BB
Cyclophosphamide
National University Hospital, Singapore
Phase 3BB
Docetaxel
Ohio State University Comprehensive Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

ANTI-PD-L1 MONOCLONAL ANTIBODY KN035 is also rated in:

neoplasmDormant
CCC
Indicative ·
52 / 100
View asset →
Advanced or Metastatic Solid TumorsDormant
CC
Indicative ·
42 / 100
View asset →
Solid Tumor, AdultDormant
D
Indicative ·
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →